SCHEMBL18637787

SCHEMBL18637787

CCCS(=O)(=O)N1CCC(COCCCCCC2CCNCC2)CC1

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
LMNA P02545 3/20 0.41
KDM4E B2RXH2 1/20 0.41
HTT P42858 1/20 0.41
GNAO1 P09471 2/20 0.40
ITGB3 P05106 10/20 0.40
ITGA2B P08514 10/20 0.40
GNAI3 P08754 1/20 0.39
GNAI1 P63096 1/20 0.39
MAPT P10636 2/20 0.38
ITGAV P06756 1/20 0.37
CHRM2 P08172 1/20 0.37
SLC6A4 P31645 1/20 0.37
F2R P25116 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7447186 0.81 GNAO1 (0.43) ALDH1A1LMNAKDM4EHTTGNAO1
SCHEMBL18637309 0.77 GPR119 (0.42) ALDH1A1LMNAKDM4EHTTSMN1; SMN2
SCHEMBL18637334 0.76 ALDH1A1 (0.52) ALDH1A1LMNAKDM4EHTTMAPT
SCHEMBL7454474 0.74 ALDH1A1 (0.37) ALDH1A1GNAO1ITGB3ITGA2BGNAI3
SCHEMBL7450677 0.73 ITGB3 (0.40) ALDH1A1LMNAKDM4EGNAO1ITGB3
SCHEMBL2846483 0.73 ALDH1A1 (0.52) ALDH1A1HTTGNAO1GNAI3GNAI1
SCHEMBL13610213 0.73 ALDH1A1 (0.52) ALDH1A1HTTGNAO1GNAI3GNAI1
SCHEMBL7455215 0.73 GNAO1 (0.47) KDM4EGNAO1ITGB3ITGA2BGNAI3
SCHEMBL16016681 0.72 TSHR (0.33)
SCHEMBL7446777 0.72 GNAO1 (0.40) ALDH1A1KDM4EGNAO1ITGB3ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2760855-B1 SUBSTITUTED CYCLOPROPYL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AS WELL AS THEIR USE IN TREATING TYPE-2 DIABETES MERCK SHARP & DOHME (US) 2017-03-15 EP disclosed